Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glycosylated Hemoglobin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06660173
What this trial is testing

Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Amgen 409
Testing effectiveness (Phase 2)Study completedNCT02057172
What this trial is testing

Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Hanmi Pharmaceutical Company Limited 254
Testing effectiveness (Phase 2)Study completedNCT00111631
What this trial is testing

DPP-IV Inhibitor in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 218
Post-approval studies (Phase 4)Study completedNCT02700477
What this trial is testing

Evaluation of Fenugreek Seed Extract In Type- 2 Diabetes: An Add-On Study

Who this might be right for
Diabetes
Chemical Resources 154
Post-approval studies (Phase 4)UnknownNCT03320031
What this trial is testing

Adding Linagliptin to Control Glycemic Variability and HbA1c in Peritoneal Dialysis Patients With Type 2 Diabetes(PDPD) With Premixed Insulin Therapy

Who this might be right for
Type 2 Diabetes MellitusPeritoneal Dialysis
Yanbing Li 232
Not applicableStudy completedNCT01626053
What this trial is testing

The Efficacy and Treatment Adherence With an Integrated Program on HbA1c Scores in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
KRJG Services Inc. 182
Not applicableStudy completedNCT02834078
What this trial is testing

Effect of BGG on Glucose Metabolism and Other Markers of Metabolic Syndrome

Who this might be right for
Pre Diabetes
Vedic Lifesciences Pvt. Ltd. 126
Testing effectiveness (Phase 2)WithdrawnNCT03686657
What this trial is testing

Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes Patients

Who this might be right for
Type 2 DiabetesHigh Blood PressureArthritis+1 more
ARKAY Therapeutics
Not applicableStudy completedNCT02137031
What this trial is testing

Continuous Glucose Monitoring and Metabolic Control in Children With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
University of Toronto 40
Large-scale testing (Phase 3)Study completedNCT01497522
What this trial is testing

Efficacy and Safety of Vildagliptin as add-on Therapy to Metformin in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Novartis Pharmaceuticals 183
Large-scale testing (Phase 3)Study completedNCT00111540
What this trial is testing

Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
AstraZeneca 456
Not applicableStudy completedNCT06064058
What this trial is testing

Assessing the Effects of HbA1c Reduction on Alleviating Nonspecific Back Pain

Who this might be right for
Back Pain Lower Back ChronicBack PainPre Diabetes+2 more
University of Baghdad 90
Large-scale testing (Phase 3)Study completedNCT01189890
What this trial is testing

Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Participants With Type 2 Diabetes Mellitus (MK-0431-251)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 480
Large-scale testing (Phase 3)Study completedNCT02752113
What this trial is testing

Effects of Empagliflozin + Linagliptin vs Metformin + Insulin Glargine on Renal and Vascular Changes in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus Type 2
Institut für Pharmakologie und Präventive Medizin 101
Not applicableStudy completedNCT04214704
What this trial is testing

Assessing the Benefits of a Painless Lancing Device Among Diabetes Patients

Who this might be right for
Type 1 DiabetesType 2 Diabetes
Jothydev's Diabetes and Research Centre 110
Large-scale testing (Phase 3)Study completedNCT01081834
What this trial is testing

The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) Trial

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 678
Not applicableStudy completedNCT01406665
What this trial is testing

Skin Autofluorescence (AF) Decision Tree in Detecting Impaired Glucose Tolerance (IGT) or Diabetes Mellitus (DM)

Who this might be right for
Diabetes MellitusImpaired Glucose Tolerance
University Medical Center Groningen 218
Not applicableStudy completedNCT07779044
What this trial is testing

Mindfulness-Based Cognitive Behavioral Program for People With Diabetes Mellitus

Who this might be right for
Diabetes MellitusDiabetes Mellitus ( Type 1 and Type 2)Depressive Symptoms
Center for Strategic Studies and Health Training, Syria 40
Post-approval studies (Phase 4)Study completedNCT02670928
What this trial is testing

Interventional Study of Active Weight Management in Patients With Type 2 Diabetes and Obesity in Routine Clinical Practice During 12 Months.

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Novartis Pharmaceuticals 130
Not applicableEnded earlyNCT04234581
What this trial is testing

The Effect of Lysulin on Glycemic Control and Advanced Glycation

Who this might be right for
Type 2 Diabetes
Juraj Koska 59
Next Page